ELRIG UK and the British Pharmacological Society collaborate
to improve scientific exchange in UK drug discovery community

Major learned societies initiate two-year strategic alliance

York and London, UK, 16 December 2019: The European Laboratory Research & Innovation Group (ELRIG) UK and the British Pharmacological Society, today announced they have formed a strategic alliance. The two-year agreement offers the organisations the opportunity to benefit from each other’s scientific communities to help strengthen their positions and reach. ELRIG and the British Pharmacological Society members will gain access to new openings for scientific exchange and collaboration between industry, academia and the clinic to help drive the successful discovery and development of new medicines across the UK.

The two groups work in complementary sectors of the UK pharmaceutical and biotech industries, academia and clinical pharmacology. The alliance creates a framework for joint working on a variety of activities that will support both communities, encouraging a multidisciplinary approach that better facilitates the exchange of ideas and information. ELRIG and the British Pharmacological Society have committed to hosting joint and complementary meetings. The alliance also offers both groups a wider reach, to help grow their audiences, and create exciting new opportunities for early career professionals’ education and training.

ELRIG’s mission is to provide leading-edge knowledge to the life sciences community on an open access basis, via a programme of scientific meetings and events. The British Pharmacological Society promotes and advances pharmacology by hosting conferences, publishing peer-reviewed journals and supporting the development of educational materials and policy proposals.

Steve Rees, Chairman of ELRIG, and VP of Discovery Biology at AstraZeneca, said: “The strategic alliance with the British Pharmacological Society formalises a joint goal of growth in the industrial and academic segments, and recognises the harmonies between our organisations. Joining forces will help us improve education, networking and other services available to our communities, allowing us to become more impactful advocates for the life sciences industry.”

Professor Steve Hill, Chairman of the British Pharmacological Society, added: “We recognise that modern drug discovery is a multi-stakeholder process, and that professionals are likely to move between sectors throughout the course of their working lives. It therefore makes sense for our programmes to represent all facets of drug discovery, and we look forward to working with ELRIG to help achieve this goal.”

For further information about ELRIG, please visit: www.elrig.org,

For further information about the British Pharmacological Society, please visit: www.bps.ac.uk

ENDS

Note to Editors:

 For high-resolution images, please contact Zyme Communications.

ELRIG
Sanj Kumar
Tel: +44 7860 89 29 44
Email: sanj.kumar@elrig.org

British Pharmacological Society
Jonathan Brüün
Tel: +44 20 7239 0186
Email: jonathan.bruun@bps.ac.uk

Zyme Communications
Katie Odgaard
Tel: +44 (0)7787 502 947
Email: katie.odgaard@zymecommunications.com

To opt-out from receiving press releases from Zyme Communications please e-mail info@zymecommunications.com. To view our privacy policy, please click here.

About ELRIG

ELRIG is a UK-based not-for-profit organisation that typically hosts 3 to 4 world-class meetings and conferences each year. ELRIG meetings are accessible to all delegates free-of-charge. To meet our open-access aims, we cover the cost of staging our events through the contributions of the exhibitors and sponsors. We also support an open policy of collaboration with other well-established and respected professional societies to add both breadth and depth to our offering.  With more than 7,000 life science professionals across the UK and Europe, our members include scientists, researchers, engineers, developers and business-people within academia, industry, government organisations and private institutes.

Follow ELRIG on LinkedIn at ELRIG UK, and on Twitter @ELRIG_UK

About the British Pharmacological Society www.bps.ac.uk

The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology, and leads the way in the research and application of pharmacology around the world. Connecting over 4,000 members from more than 60 countries, it is a global community at the heart of pharmacology.

Follow the British Pharmacological Society on LinkedIn at British Pharmacological Society, and on Twitter @BritPharmSoc

Menu